Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a small, open label pilot study comparing upper and lower GI routes of administration did not show any differences44”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [44]
In the citing paper
“The human gut microbiota can restrict the growth of pathogens to prevent them from colonizing the intestine (‘colonization resistance’).”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
In the citing paper
“Gut microbiota with high diversity have higher colonization resistance than gut microbiota with low diversity as a result of antibiotic treatment [28].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
Citations
Cites
Measuring biological diversity
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,621
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 3×
“exist in a complex symbiosis with their host [5].”
BackgroundInfluentialSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501 · cited 1×
“The distance matrix was fed into DOTUR [8] to group the sequences into operational taxonomic units (OTUs), calculate ecological diversity measures (including the Shannon index [9]), and generate rarefaction curves by use of an OTU definition of 97% sequence similarity.”
MethodAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 1×
“Diarrhea is a common side effect of the administration of antibiotics, with Clostridium difficile being responsible for most of the severe cases of antibiotic-associated diarrhea (AAD), including the development of pseudomembranous colitis [1].”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundKyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804 · cited 1×
“difficile toxin [11].”
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundAas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518 · cited 1×
“individuals to patients with RCD [4, 15]—is to alter the patient’s microbiome and to restore colonization resistance.”
BackgroundBACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“microbiota is that of “colonization resistance” [10].”
Cited by
Items 801–900 of 999
Clostridium difficileinfection: New insights into therapeutic options
Kachrimanidou, M., Sarmourli, T., Skoura, L., Metallidis, S., & Malisiovas, N. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1027171 · Cited by 6
“Risk factors predisposing colonized patients to develop symptoms include antibiotic treatment and advanced age (Bartlett, 2002; Chang et al., 2008; Miller et al., 2010).”
BackgroundVestal, R. (2015) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2015.08.006 · Cited by 3
Parallels Between Mammals and Flies in Inflammatory Bowel Disease
Christofi, T., & Apidianakis, Y. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_7 · Cited by 3
“Clostridium difficile can take advantage of the antibiotic-mediated reduction in microbial diversity to infect the adult gut (Chang et al. 2008).”
BackgroundWilcox, M. H., Cornely, O. A., Guery, B. P., Longshaw, C. M., Georgopali, A., Karas, A., Kazeem, G., Palacios, J., & Vehreschild, M. J. G. T. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz436 · Cited by 3
“These studies also showed that fidaxomicin was associated with lower rates of recurrence compared with vancomycin (14% versus 26%) [15], thought to be the result of gut microbiota preservation [8, 11, 12].”
BackgroundImdad, A., Minkoff, N. Z., Tanner‐Smith, E. E., Zackular, J. P., Acra, S. A., & Nicholson, M. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013871 · Cited by 5
Shang, Y., Chang, X., Khan, F. U., Dupont, S., Hu, M., & Wang, Y. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741440 · Cited by 4
Rompiendo paradigmas. Trasplante de microbiota intestinal: reporte preliminar
Zamudio-Tiburcio, Á., Bermúdez-Ruiz, H., Lezama-Guzmán, H. R., Guevara-Ortigoza, M. D. P., Islas-Solares, E., & Sosa-López, F. A. (2017) · Cirugía y Cirujanos · doi:10.1016/j.circir.2016.11.017 · Cited by 6
Singh, N., & Khandey, P. (2018) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/14196_24 · Cited by 5
Syndromes of Enteric Infection
LaRocque, R. C., & Calderwood, S. B. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00098-9 · Cited by 4
Les diarrhées post-antibiotiques
Eckert, C., & Barbut, F. (2010) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(10)70697-3 · Cited by 3
Clostridium difficile infection and gut microbiota
Zalig, S., & Rupnik, M. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.005 · Cited by 3
Treating recurrent C. difficile infection—the challenge continues
Surawicz, C. M. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.240 · Cited by 3
Le microbiote dans les diarrhées infectieuses
Surawicz, C. M. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70005-1 · Cited by 3
Fecal microbiota transplantation
González-Altamirano, J., Maldonado-Garza, H. J., Garza‐González, E., & Bosques‐Padilla, F. (2015) · Medicina Universitaria · doi:10.1016/j.rmu.2015.06.003 · Cited by 3
FMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
Kates, A., Tischendorf, J. S., Schweizer, M. L., Herwaldt, L. A., Samore, M. H., Dukes, K., Gerding, D. N., Diekema, D. J., & Safdar, N. (2018) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.311 · Cited by 4
“difficile,(25,26) but these antibiotics have activity against other gut bacteria, limiting the ability of the microbiota to fully recover following CDI and predisposing patients to recurrence.(27) Although other factors may also explain why patients have recurrence (eg, low serum antibody response to C.”
BackgroundClostridium difficile : What the surgeon needs to know
Hrebinko, K. A., & Zuckerbraun, B. S. (2017) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2017.09.006 · Cited by 3
Wang, W. (2008) · UWSpace (University of Waterloo) · Cited by 5
Temporal Modulation of Gut Microbiome and Metabolome by Morphine
Wang, F. (2015) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 5
Stable Engraftment of a Human Gut Bacterial Microbiome in Double Humanized BLT-micePreprint
Daharsh, L., Ramer‐Tait, A. E., & Li, Q. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/749093 · Cited by 3
“Several studies have highlighted the importance of microbiome diversity within the 329 gut and have linked low gut microbiome diversity with several disease conditions[26, 27].”
BackgroundThanissery, R., McLaren, M. R., Rivera, A. J., Reed, A. D., Betrapally, N. S., Burdette, T., Winston, J. A., Jacob, M. E., Callahan, B. J., & Theriot, C. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/822577 · Cited by 3
Cross-feeding enables robust coexistence between four bacterial species
Sulheim, S., Teixeira, M., Ulrich, E., Gillon, A., Testa, S., Padmanabha, P., Machado, D., & Mitri, S. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2607664123 · Cited by 4
Quera, R., Paulina Núñez, F., von Mühlenbrock, C., & Espinoza, R. (2024) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.03.005 · Cited by 5
Clostridioides difficile Infections: Prevention and Treatment Strategies
Levy, E. I., Dinleyici, M., Dinleyici, E. Ç., & Vandenplas, Y. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-58572-2_11 · Cited by 3
Microbiome-Based Treatment for Gastrointestinal Tract Disorders
Abbas, S., Khan, A., Akhter, T. S., Samad, A., Chinnam, S., Mushtaq, S., Usman, M., Khan, A., & Akash, M. S. H. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_12 · Cited by 3
Nguyen, J. D. K., Yohannes, K., Setiady, I., Phillips, E. C., Hays, R. A., Behm, B. W., Warren, C. A., & Shin, J. H. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251334517 · Cited by 2
Gastrointestinal Microbiota and the Neural System
Philip, V., & Berčík, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00027-6 · Cited by 3
[Successful home-made fecal transplant for an elderly woman].
Cherem, J. H., & Hoyo-Ulloa, I. (2014) · PubMed · Cited by 2
Navigating the Pediatric Microbiome: Emerging Evidence and Clinical Implications
Kassam, Z., & Murray, T. S. (2014) · Current Pediatrics Reports · doi:10.1007/s40124-014-0040-1 · Cited by 2
Challenges and opportunities in the management ofClostridium difficileinfection
DuPont, H. L. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.939630 · Cited by 2
“Enhancing biodiversity of intestinal flora [63] with restoration of normal fecal bile acid composition [64] in patients with multiple recurrent CDI with bacteria harvested from stools of healthy donors is effective in most cases with durable response [65].”
BackgroundFecal Bacteriotherapy for Clostridium difficile Infections — Its Time Has Come
Avery, L., & Hasan, M. S. (2013) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2013.07.002 · Cited by 2
The Human Microbiota and Pathogen Interactions
Walker, A. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00019-6 · Cited by 3
Fecal Microbiota Transplants: Current Knowledge and Future Directions
Chis, R., Sheth, P. M., & Petrof, E. O. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_11 · Cited by 2
Gut Microbiology – A Relatively Unexplored Domain
O’Donovan, C. M., O’Sullivan, Ó., & Cotter, P. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.09233-5 · Cited by 2
Marques-Afonso, A.-T., Fernández-Castro, I., Vázquez-Agra, N., Barrera-López, L., Alende-Castro, V., Macía-Rodríguez, C., Mateo‐Mosquera, L., & Novo‐Veleiro, I. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03982-w · Cited by 2
Common nutrition and health issues of food in the Balkans
Jasar, D., & Curcic, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820782-6.00005-0 · Cited by 3
Holmes, I. A., & Gründler, M. C. (2022) · Molecular Ecology · doi:10.1111/mec.16733 · Cited by 2
Susilowati, I. T., & Suwarni, S. (2023) · PARAHITA Jurnal Pengabdian kepada Masyarakat · doi:10.25008/parahita.v3i2.78 · Cited by 2
Generation and robustness of Boolean networks to model Clostridium difficile infection
Travisany, D., Chacc, E. G., Latorre, M., Cortés, M. P., & Maass, A. (2019) · Natural Computing · doi:10.1007/s11047-019-09730-0 · Cited by 2
Thobari, J. A., Damayanti, W., Mulyadi, A. W. E., Haposan, J. H., Setiyaningrum, A., Indraguna, S., Sutarman, S., Arifah, N., Rahayu, A. D., Khasanah, F., et al. (2021) · Jurnal Pengabdian Kepada Masyarakat · doi:10.22146/jpkm.62861 · Cited by 2
Lauro, F. M., & Williams, T. J. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7475-4_33 · Cited by 2
Editorial: The Role of Compassion in the Practice of Evidence-Based Medicine
McFarland, L. V. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.489 · Cited by 2
Ausique, J. J. S. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.11.2010.tde-16032010-161656 · Cited by 3
Bacterial, Viral, and Toxic Causes of Diarrhea, Gastroenteritis, and Anorectal Infections
Cohen, M. B. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch62 · Cited by 2
An introduction to microbial dysbiosis
Curtis, M. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch2 · Cited by 2
Within-host competition sparks pathogen molecular evolution and perpetual microbiota dysbiosisPreprint
Stevens, E. J., Li, J., Hector, T. E., Drew, G., Hoang, K. L., Greenrod, S. T. E., Paterson, S., & King, K. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.03.610829 · Cited by 2
“Here, upon initial invasion of nematode hosts, S. aureus displaced resident microbiota (in terms of number and diversity) worsening disease outcome, comparable to results observed with other bacterial pathogens 63 .”
ResultResource diversity begets stability in complex ecosystemsPreprint
Rowland-Chandler, J., Shou, W., & Goyal, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.20.683391 · Cited by 4
“For example, stability the ability of a community to return to the original steady state after a small perturbation can preserve the healthy metabolism of gut microbiomes, while pathogen invasion can drive the emergence of low-diversity, fluctuating diseased states [13, 14].”
Functional Nucleic Acids as Bacterial Biosensors: A Focus on Clostridioides difficile Infection
Chow, K., & Li, Y. (2024) · Analysis & Sensing · doi:10.1002/anse.202400056 · Cited by 2
Lo, H. C., Mettu, R., Chen, C.-Y., Li, S., & Wu, C. (2025) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5c00290 · Cited by 1
Lecoutour, A., Mesa, V., Couturier, J., Delannoy, J., Pigneur, B., & Barbut, F. (2025) · Anaerobe · doi:10.1016/j.anaerobe.2025.102980 · Cited by 1
Wan, S., Li, M., Li, W., Ren, Y., Wu, Y., Luo, Q., & Gong, W. (2025) · Nutrition Journal · doi:10.1186/s12937-025-01198-2 · Cited by 1
“Diminished microbial richness has also been associated with obesity [21], inflammatory bowel disease [22], and recurrent Clostridium difficile-associated diarrhea [23].”
Microbiota management: a perspective for kidney transplant patients
Souza, C. S., Câmara, N. O. S., & Alves-Silva, T. (2026) · Frontiers in Transplantation · doi:10.3389/frtra.2026.1703048 · Cited by 1
Microbial shifts in early life: the pediatric gut microbiome and its role in health and disease
Waghmode, S., Viswanathan, R., Koligudde, V., Umare, P., & Lavania, M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2681763 · Cited by 1
“118 Patients with recurrent CDI exhibited reduced conversion of primary to secondary bile acids a crucial process since primary bile acids promote C. difficile germination and growth, while secondary bile acids inhibit it.”
Problemfeld Clostridium-difficile-Infektion
Ebigbo, A., & Messmann, H. (2013) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-013-0258-7 · Cited by 1
Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea
Hundal, R., Kassam, Z., Johnstone, J., Lee, C., & Marshall, J. K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009295 · Cited by 1
RetractedFecal Microbiota Transplantation: An Interest in IBD?
Kahn, S. A., Goeppinger, S. R., & Rubin, D. T. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360715 · Cited by 1
Comment traiter une infection digestive à Clostridium difficile en 2014 ?
Barbut, F., Guery, B. P., & Eckert, C. (2014) · Réanimation · doi:10.1007/s13546-014-0867-z · Cited by 2
Updated Management of Clostridium difficile Infections in Post-Acute Care Settings
Hector, M. C. M. (2015) · Journal of General Practice · doi:10.4172/2329-9126.s1-004
“difficile; 2) produce acids that lower the pH of the local gut environment and toxins that inhibit the growth of other bacteria; 3) inhibit adhesion and decrease invasion of pathogenic organisms to the colonic epithelium; and 4) modulate both the innate and adaptive immune systems by stimulating receptors [40-42].”
BackgroundAn Overview of the Diagnosis and Management ofClostridium difficileInfection
Hooper, M. H., Kelly, U. M., & Marik, P. E. (2012) · Hospital Practice · doi:10.3810/hp.2012.02.952 · Cited by 1
Recent Update in Fecal Microbiota Transplantation
Kim, H., Kang, K., Kim, S.-J., & Im, E. (2014) · The Korean Journal of Microbiology · doi:10.7845/kjm.2014.4072 · Cited by 2
“CDI를 겪 고 있는 환자들을 대상으로 위장관내 미생물군락을 조사한 결과 Firmicutes와 Bacteroidetes가 감소하였다(Chang et al., 2008).”
Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective
Borody, T. J., & Finlayson, S. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.013 · Cited by 1
Fecal Microbial Transplant: For Whom, How, and When
Kahn, S. A., & Kaplan, J. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_35 · Cited by 1
Fecal microbiota transplantation: why, who, how?
Yalçın, S. S., & Kanatlı, M. Ç. (2015) · Pamukkale Medical Journal · doi:10.5505/ptd.2015.22448 · Cited by 2
“Rekürren CDE görülen hastalarda, dışkıdaki filogenetik çeşitlilikte azalma olduğu bilinmektedir [16].”
Manipulation of the Host-Cell Pathways by Bacterial Enteropathogens
Schiffrin, E. J., Marteau, P. R., & Brassart, D. (2014) · CRC Press eBooks · doi:10.1201/b16442-7 · Cited by 1
Taur, Y. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_51 · Cited by 3
Allergie und das Mikrobiom des Darms – Teil 1
Stockert, K. (2015) · Deutsche Zeitschrift für Akupunktur · doi:10.1016/s0415-6412(15)30038-2 · Cited by 1
“Hospitalisierung und Gestationsalter Bei Frühchen zeigte sich eine geringe Vielfalt der fäkalen Mikrobiota [32], eine hohe inter-individuelle Variabilität und abrupte Verlagerungen von Bakterienarten und -stämmen, besonders ein vermehrtes Vorkommen von Clostridium diffi cile, die dann auch häufi g rezidivierende Infek…”
BackgroundMeneses, R., Filardi, K. F. X. C., Bagano, P., Machado, R. G., & Fernandes, S. (2018) · International Journal of Nutrology · doi:10.1055/s-0038-1669391 · Cited by 3
Das Mikrobiom als Drehscheibe für Nebenwirkungen der Protonenpumpenhemmer-Therapie
Horvath, A., & Stadlbauer, V. (2020) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/a-1312-7587 · Cited by 1
“Wird die Diversität des Mikrobioms reduziert, verliert es zu einem gewissen Grad auch seine Kolonisationsresistenz [27,28].”
BackgroundMarsh, J. W., & Harrison, L. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801214-7.00010-7 · Cited by 2
SEASON GAP score: A predictor of Clostridioides difficile infection among patients with tube feeding
Masaki, M., Matsuo, T., Kobayashi, D., & Mori, N. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.04.011 · Cited by 1
Microbioma y enfermedades crónicas
Khouri, L. S., Flores-Andrade, X. A., González, R. S. M., Olmos, I. O. V., Velez-Pintado, M., & Durán, J. P. G. (2022) · Anales Médicos de la Asociación Médica del Centro Médico ABC · doi:10.35366/108781 · Cited by 1
Mahmoud, N. (2023) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2023.309506 · Cited by 1
“It is compared through a defined automated protein database that permits for bacterial identification (Clark et al., 2013).”
Mansoor, A., O’Neil, C. A., & Kwon, J. H. (2023) · Anaerobe · doi:10.1016/j.anaerobe.2023.102772 · Cited by 1
Pediatric probiotic culture survival study in acidic pH using an in vitro model
Dhillon, S., Renwick, S., Berdy, B. M., & Dhillon, A. (2022) · Journal of Emerging Investigators · doi:10.59720/22-099 · Cited by 1
“Antimicrobial treatment has additional risks associated with it, including the selection of antibiotic-resistant strains of bacteria and the development of Clostridium difficile associated diarrhea (22).”
BackgroundKim, M. H., Kim, J., Ra, H., Jeong, S., Park, Y. S., Won, D., Lee, H., & Kim, H. (2024) · Emerging infectious diseases · doi:10.3201/eid3005.231588 · Cited by 1
Joo, M.-K., Ma, X., Shin, J., Shin, Y.-J., & Kim, D. (2025) · Microbes and Infection · doi:10.1016/j.micinf.2025.105560 · Cited by 4
Ajami, N. J., & Petrosino, J. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802241-2.00025-0 · Cited by 2
The interplay between genetics, the microbiome, DNA‐methylation & gene‐expression
Bonder, M. J. (2017) · Cited by 1
Berinstein, J. A., Steiner, C. A., Roth, K.-H., Briggs, E., Rao, K. K., & Higgins, P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06123-7 · Cited by 1
The Microbiome Sets the Stage for Cholera
Sokol, N. S., & Newton, I. L. G. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.002 · Cited by 1
Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach
Silva, A. R., Bernardo, A., de Mesquita, M. F., Patto, J. V., Moreira, P. A. M., Padrão, P., & Silva, M. L. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4808-0.ch015 · Cited by 4
Rosales, S. P. D. L. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.36.005905 · Cited by 1
Stenberg, R., Brummer, R. J., & Norén, T. (2022) · Acta Paediatrica · doi:10.1111/apa.16363 · Cited by 1
Clostridium (Now Clostridioides) difficile-Associated Disease
Hays, R. A., & Surawicz, C. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_71 · Cited by 1
Lung Microbiota and Its Impact on the Mucosal Immune Phenotype
Wu, B. G., & Segal, L. N. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch7 · Cited by 3
Tran, V., Phan, J., Nulsen, B., Huang, L., Kaneshiro, M., Weiss, G. A., Ho, W. W., Sack, J. L., Ha, C. Y., Uslan, D. Z., et al. (2018) · ACG Case Reports Journal · doi:10.14309/02075970-201805120-00013 · Cited by 4
Considering humans as habitat reveals evidence of successional disease ecology among human pathogens
Fefferman, N. H., Price, C. A., & Stringham, O. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001770 · Cited by 1
“Studies have provided both theoretical insight and clinical recommendations in application to gut [45,46], vaginal [47], oral [48], nasal [49], and dermal [50] microbiota, exploring the transition from established but harmless colonization, to clinical pathology, and what might be done to mitigate medical risks via re…”
BackgroundBacterial Colonization and Host Immunity
Mihu, C. N., Vigil, K. J., & Adachi, J. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_15 · Cited by 1
Clostridium difficileInfection and Pseudomembranous Colitis
Moss, A. C., & LaMont, J. T. (2010) · doi:10.1002/9781444328417.ch50 · Cited by 1
Fecal Microbiota Transplantation: Clinical and experimental studies
van Nood, E. (2015) · Data Archiving and Networked Services (DANS) · Cited by 4
Placental, oral and vaginal microbiomes and birth outcomes in rural Malawi
Doyle, R. (2016) · UCL Discovery (University College London) · Cited by 1
Clostridium difficile : new challenges for an old foe
Tillotson, G., & Weiss, K. (2013) · doi:10.2217/ebo.13.271 · Cited by 1
The microbiota as target for therapeutic intervention in pediatric intestinal diseases
Vecchio, A. L., & Guarino, A. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch31 · Cited by 1
The urinary microbiota composition remains stable over time and under various storage conditionsPreprint
Bundgaard‐Nielsen, C., Ammitzbøll, N., Isse, Y. A., Muqtar, A., Jensen, A.-M., Leutscher, P. D. C., Arenholt, L. T. S., Hagstrøm, S., & Sørensen, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.13.875187 · Cited by 1
Biome Profiling and Clinical Parasitology: Tools for Gut Microbiota RestoringPreprint
Pane, S., Ristori, M. V., Gardini, S., russo, A., CHIERICO, F. D., & Putignani, L. (2021) · Preprints.org · doi:10.20944/preprints202110.0167.v1
“difficile infections are characterized by almost monomicrobial bacterial distributions of the fecal microbiota [20].”
BackgroundDiet‐Based Microbiome Modulation: You are What You Eat
Li, J., Qu, Z., Liu, F., Hao, J., Pan, Y., Guo, S., & Ho, C. L. (2022) · Wiley eBooks · doi:10.1002/9783527825462.ch1 · Cited by 1
Clostridium difficile Infection and Pseudomembranous Colitis
Vaughn, B. P., & LaMont, J. T. (2016) · Wiley eBooks · doi:10.1002/9781119127437.ch55 · Cited by 1
Antibiotic-Associated Diarrhea
Theriot, C. M., & Young, V. B. (2014) · Springer eBooks · doi:10.1007/978-1-4614-6418-1_64-3 · Cited by 1
Self-citationJesús, G. H.-D., Zhang, J. L., Birhanu, B., & Grinspan, A. M. (2023) · Research Square · doi:10.21203/rs.3.rs-2977973/v1 · Cited by 1
Hay, M., Hinsu, A., KORINGA, P. G., Pandit, R. J., Liu, P., Parekh, M. J., Jakhesara, S. J., Dai, X., Crotta, M., Fosso, B., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2381640/v1 · Cited by 1
Metadata
- Authors
- Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B.
- Affiliations
- Michigan State University (US)
- Corresponding author
- Young, Vincent B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 197
- Issue
- 3
- Pages
- 435-438
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139607253
- Cited by
- 1,010
- References
- 15
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 36 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 69 · 2019: 59 · 2018: 107 · 2017: 78 · 2016: 77 · 2015: 88 · 2014: 87 · 2013: 78 · 2012: 53
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile, fecal microbiota, microbial diversity, antibiotic-associated diarrhea, 16S rRNA gene sequencing, bacterial community composition, dysbiosis, microbiota restoration
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Drug Administration Schedule, Enterocolitis, Pseudomembranous, Feces, Female, Humans, Male, Phylogeny, Recurrence, Reference Values, Genetic Variation, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.